ALTHOUGH the title assigned to me is broad, I think it will be most useful if I confine my remarks on the biologics control of virus vaccines to some general considerations concerning rubella vaccine. The subject of this conference has brought up a number of novel features, and rubella vaccine will prove to be not just another new vaccine, but a different vaccine.
I am rather pleased that the word "vaccine" does not appear in the title of this conference. "Rubella immunization" is much more appropriate at this time. Were the word "vaccine" applied only to products that have reached the stage of development at which they can be considered for licensing or its equivalent, much confusion could be avoided. Misunderstandings occur when a preparation is administered to animals under experimental conditions and referred to as a vaccine. It is too much to expect that a new term be
Murray R. Biologics Control of Virus Vaccines. Am J Dis Child. 1969;118(2):334–337. doi:10.1001/archpedi.1969.02100040336031
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: